Psychedelic highlights | January 25 – 29

Shares :

Psychedelic highlights | January 25 – 29

Here is a summary of the news from the last week in the psychedelics market. The value of the psychedelics market is more than $100 billion according to Cannacord most recent report.

Psychedelic market value by company

Last week performance

M2Bio SciencesWUHN$0.409+ 2.25 %
Psyched WellnessPSYC$0.38+ 2 %
Field TripFTRP$4.85– 1.2 %
Revive TherapeuticsRVV$0.56– 5 %
Red Light HollandsTRIP$0.48– 5.8 %
CompassCMPS$43.83– 9 %
Cybin Inc. CYBN$2.08– 12.9 %
Mind CureMCUR$43.83– 14.8%
MindMedMMED$3.80– 17.8 %
NuminusNUMI$1.30– 18.75 %

Story of the week

1. Financier Sheldon Inwentash Joins M2Bio Sciences (Wuhan General Group) as Strategic Advisor [news release]

M2Bio Sciences is pleased to announce today that the Company has entered into an advisory agreement with Sheldon Inwentash.

Sheldon is well-known in the North American capital markets for his investment prowess and strategies, for revolutionizing the resource investment model and for creating very significant shareholder value and returns through early investments

Read the full article HERE

2. Numinus Wellness Closes Q1 2021 with Strong Cash Position and Industry Firsts [news release]

Numinus today announced its financial results for the first quarter for the three months ended November 20, 2020 (“Q1 2021”). After achieving two industry firsts, launching new compassionate access trials, and augmenting its clinical and research activity, Numinus meaningfully expanded its industry presence in Q1 2021

Read the full news HERE

3. Mydecine Innovations Group Sponsors Study on Neuron Level Response to Psilocybin at University of Maryland and Files Application to list to the NASDAQ [news release]

Mydecine Innovations Group™ announced that it is sponsoring a study titled: “Facilitating extinction of fear with psilocybin: Model development of biomarkers and mechanisms,” at the University of Maryland School of Medicine in Baltimore, Maryland.

Read the full news HERE

4. Field Trip Health Ltd. Common Shares to Trade on the OTCQX Best Market and Announces Opening of Field Trip Health Center in Atlanta [news release]

Field Trip Health Ltd announce its common shares have been approved for trading on the OTCQX® Best Market (“OTCQX”) retaining its current symbol FTRPF, effective as of the opening of trading today, January 28, 2021.

And more, Field Trip announced the opening of their fifth location in the United States in the city of Atlanta, GA, one of many locations that Field Trip is planning to open in 2021.

Read the full news HERE

5. MINDCURE Announces Pre- and Post-Psychedelic Therapy Adaptogen Supplements, Defining New Product Category [news release]

Mind Cure  is pleased to announce it has moved out of development and is finalizing its proprietary formulation of all-natural integrative medicines intended to prepare and support patients of psychedelic therapies. 

Read the full news HERE

6. Nova Launches Preclinical Autism Spectrum Disorder Therapeutic Study [news release]

Nova Mentis Life Science Corp. is pleased to announce that it has commenced the diagnostic and treatment phase of its ongoing preclinical model study of autism spectrum disorder (ASD).

Read the full news HERE

7. Core One Labs Announces Vocan Assembles Equipment to Produce Biosynthesized Psilocybin [news release]

Core One Labs  is pleased to announce its wholly-owned subsidiary Vocan Biotechnologies Inc. (“Vocan“) has assembled the necessary equipment, which will allow the laboratory to commence the process of recombinant production of psilocybin.

Read the full news HERE

Sign up for MORE news updates !

This article is written and published by The Cannabis Stock

Disclaimer : The Cannabis Stock wants to promote the cannabis market with the best articles and news on the market. The Cannabis Stock does not recommend selling or buying any of the company mentioned and is not responsible for any losses that may result. The Cannabis Stock are engaged in the business of marketing and advertising companies

The Cannabis Stock and its employees may from time to time own shares of the companies named in the articles. All the facts reported by the cannabis stock are information that comes directly from the companies, from their website or on Sedar and are only published as information.

Click on a star to rate this article !

Average rating 5 / 5. Vote count: 1

No votes so far! Be the first to rate this post.

Shares :